HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Peptides / October 15, 2026

Three pathways. One higher standard for peptides.

Inside the planned approach to clinical services, research and institutional supply.

Three planned peptide pathways: clinical services, research, institutional supply

Clear Health Pass has set out three distinct planned business pathways: cash-pay consumer telehealth, TRIBAL-sponsored research, and physician-office and institutional supply. None has launched.

Different pathways, different permissions

Clinical services would connect patients with independent licensed clinicians and licensed pharmacies. Research would be sponsored by TRIBAL, with CHP providing contracted nonclinical services. Institutional services would include platform licensing and administrative supply support.

Each pathway requires its own authorizations. A prescription, an office-stock release and an investigational release cannot substitute for one another.

The opportunity is in the infrastructure

Assessment, informed consent, traceable supply, follow-up and credible evidence are the organizing principles. They are planned capabilities, not demonstrated clinical outcomes.